The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Tissue Endothelin-1 Immunoreactivity in the Active Coronary Atherosclerotic Plaque: A Clue to the Mechanism of Increased Vasoreactivity of the Culprit Lesion in Unstable Angina
Abstract
Background The pathomorphological substrate of complicated coronary atherosclerotic lesions underlying unstable angina is characterized by a localized chronic inflammatory process. Functionally, coronary lesions associated with unstable angina demonstrate an enhanced vasoreactivity. Endothelin-1 is a potent vasoconstrictor peptide produced not only by endothelial cells but also by macrophages and polymorphonuclear leukocytes, the cell types characteristic of inflammation. Methods and Results By use of immunohistochemical techniques, we examined the presence of endothelin-1 in coronary atherosclerotic plaque tissue obtained by directional coronary atherectomy of primary lesions from 50 consecutive patients. The tissue specimens of 43 of 50 patients (86%) demonstrated endothelin-1–like immunoreactivity. Endothelin-1–like immunoreactivity preferentially localized to macrophage-rich areas, to hypercellular regions rich in microvessels, and to plaque areas with evidence of prior hemorrhage. Double-immunolabeling revealed that both macrophages (HAM56 positive) and intimal smooth muscle cells (α-actin positive) demonstrated cytoplasmic immunostaining for endothelin-1. Semiquantitative analysis of endothelin-1–like immunostaining revealed significantly (P<.005) higher staining grades in active (1.86±0.15, n=40) compared with nonactive lesions (0.78±0.35, n=10): endothelin-1 staining grades were significantly (P<.001) lower in patients with stable angina (0.69±0.19, n=13) than in patients with crescendo angina (1.82±0.30, n=11), with angina at rest (2.08±0.21, n=12), or with angina after myocardial infarction (2.0±0.26, n=14). Conclusions Endothelin-1 immunostaining of atherosclerotic tissue localizes predominantly with plaque components indicative of chronic inflammatory processes. The increased tissue endothelin-1–like immunoreactivity in active coronary atherosclerotic lesions may provide a clue to the mechanisms of increased vasoreactivity of the culprit lesion in acute ischemic syndromes, which is the clinical substrate of the active coronary atherosclerotic plaque.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel potent vasoconstrictor peptide produced by vascular endothelial cells
Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., & Masaki, T. (1988) · Nature · doi:10.1038/332411a0 · Cited by 10,729
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Nonparametric Statistical Methods
(1999) · Technometrics · doi:10.1080/00401706.1999.10485954 · Cited by 6,090
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201303260506 · Cited by 3,725
Cordell, J. L., Falini, B., Erber, W. N., Ghosh, A. K., Abdulaziz, Z., MacDonald, S., Pulford, K. A., Stein, H., & Mason, D. Y. (1984) · Journal of Histochemistry & Cytochemistry · doi:10.1177/32.2.6198355 · Cited by 3,148
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260406 · Cited by 2,717
Inoue, A., Yanagisawa, M., Kimura, S., Kasuya, Y., Miyauchi, T., Goto, K., & Masaki, T. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2863 · Cited by 2,517
The pathogenesis of coronary artery disease and the acute coronary syndromes (First of two parts)
Fuster, V. (1992) · New England Journal of Medicine · Cited by 1,954
van der Wal, A. C., Becker, A. E., van der Loos, C. M., & Das, P. K. (1994) · Circulation · doi:10.1161/01.cir.89.1.36 · Cited by 1,910
Ylä-Herttuala, S., Palinski, W., Rosenfeld, M. E., Parthasarathy, S., Carew, T. E., Butler, S., Witztum, J. L., & Steinberg, D. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114271 · Cited by 1,880
RICHARDSON, P. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90953-7 · Cited by 1,258
Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease.
Vita, J. A., Treasure, C. B., Nabel, E. G., McLenachan, J. M., Fish, R. D., Yeung, A. C., Vekshtein, V. I., Selwyn, A. P., & Ganz, P. (1990) · Circulation · doi:10.1161/01.cir.81.2.491 · Cited by 1,173
Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture.
Moreno, P. R., Falk, E., Palacios, I. F., Newell, J. B., Fuster, V, & Fallon, J. T. (1994) · Circulation · doi:10.1161/01.cir.90.2.775 · Cited by 1,108
Zeiher, A. M., Drexler, H., Wollschläger, H., & Just, H. (1991) · Circulation · doi:10.1161/01.cir.83.2.391 · Cited by 995
Self-citationCirculating and Tissue Endothelin Immunoreactivity in Advanced Atherosclerosis
Lerman, A., Edwards, B. S., Hallett, J. W., Heublein, D. M., Sandberg, S. M., & Burnett, J. C. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110033251404 · Cited by 953
Barger, A. C., Beeuwkes, R., Lainey, L. L., & Silverman, K. J. (1984) · New England Journal of Medicine · doi:10.1056/nejm198401193100307 · Cited by 849
Endothelin stimulates c‐fos and c‐myc expression and proliferation of vascular smooth muscle cells
Komuro, I., Kurihara, H., Sugiyama, T., Takaku, F., & Yazaki, Y. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)80489-7 · Cited by 726
The Pathogenesis of Atherosclerosis: Atherogenesis and Inflammation
Munro, J. M., & Cotran, R. S. (1989) · Pathology Reviews · 1989 · doi:10.1007/978-1-4612-4502-5_10 · Cited by 698
Bertrand, M. E., LaBlanche, J. M., Tilmant, P. Y., Thieuleux, F. A., Delforge, M. R., Carre, A. G., Asseman, P., Berzin, B., Libersa, C., & Laurent, J. M. (1982) · Circulation · doi:10.1161/01.cir.65.7.1299 · Cited by 502
Integrated cardiac, renal, and endocrine actions of endothelin.
Miller, W. L., Redfield, M. M., & Burnett, J. C. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113876 · Cited by 473
Willerson, J. T., Golino, P., Eidt, J., Campbell, W. B., & Buja, L. M. (1989) · Circulation · doi:10.1161/01.cir.80.1.198 · Cited by 457
Endothelins, peptides with potent vasoactive properties, are produced by human macrophages.
Ehrenreich, H., Anderson, R. W., Fox, C. H., Rieckmann, P., Hoffman, G. S., Travis, W. D., Coligan, J. E., Kehrl, J. H., & Fauci, A. S. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.6.1741 · Cited by 457
Yang, Z. H., Richard, V, von Segesser, L., Bauer, E., Stulz, P., Turina, M., & Lüscher, T. F. (1990) · Circulation · doi:10.1161/01.cir.82.1.188 · Cited by 439
Endothelium-derived relaxing factor and coronary vasospasm.
Vanhoutte, P. M., & Shimokawa, H. (1989) · Circulation · doi:10.1161/01.cir.80.1.1 · Cited by 416
Inflammation and Coronary Artery Disease
Alexander, R. W. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408183310709 · Cited by 400
Antioxidants and atherosclerosis. A current assessment.
Steinberg, D. (1991) · Circulation · doi:10.1161/01.cir.84.3.1420 · Cited by 392
McFadden, E. P., Clarke, J. G., Davies, G. J., Kaski, J. C., Haider, A. W., & Maseri, A. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103073241002 · Cited by 360
Boulanger, C. M., Tanner, F. C., Béa, M. L., Hahn, A. W., Werner, A., & Lüscher, T. F. (1992) · Circulation Research · doi:10.1161/01.res.70.6.1191 · Cited by 352
Growth factor activity of endothelin on vascular smooth muscle
Bobik, A., Grooms, A., Millar, J. A., Mitchell, A., & Grinpukel, S. (1990) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1990.258.3.c408 · Cited by 316
IMPARATO, A. M., RILES, T. S., MINTZER, R., & BAUMANN, F. G. (1983) · Annals of Surgery · doi:10.1097/00000658-198302000-00012 · Cited by 279
Endothelin-1 and Endothelin Receptor mRNA Expression in Normal and Atherosclerotic Human Arteries
Winkles, J. A., Alberts, G. F., Brogi, E., & Libby, P. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1327 · Cited by 213
Coronary artery spasm and vasoconstriction. The case for a distinction.
Maseri, A., Davies, G., Hackett, D., & Kaski, J. C. (1990) · Circulation · doi:10.1161/01.cir.81.6.1983 · Cited by 212
Resink, T. J., Hahn, A. W. A., Scott‐Burden, T., Powell, J. S., Weber, E., & Bühler, F. R. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91171-n · Cited by 212
Brogi, E., Winkles, J. A., Underwood, R., Clinton, S. K., Alberts, G. F., & Libby, P. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116847 · Cited by 190
Vasoreactivity of the culprit lesion in unstable angina.
Bogaty, P., Hackett, D., Davies, G., & Maseri, A. (1994) · Circulation · doi:10.1161/01.cir.90.1.5 · Cited by 168
Circulating and tissue endothelin immunoreactivity in hypercholesterolemic pigs.
Lerman, A., Webster, M. W., Chesebro, J. H., Edwards, W. D., Wei, C. M., Fuster, V, & Burnett, J. C. (1993) · Circulation · doi:10.1161/01.cir.88.6.2923 · Cited by 158
Mitchinson, M. J., & Ball, R. Y. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92341-5 · Cited by 131
Modified low density lipoproteins activate human macrophages to secrete immunoreactive endothelin
Martin‐Nizard, F., Sqalli-Houssaini, H., Lestavel, S., Duriez, P., & Fruchart, J. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)81167-7 · Cited by 81
Zeiher, A. M., Schächinger, V., Weitzel, S., et al. (1991) · Circulation · doi:10.1161/01.cir.83.5.1519 · Cited by 75
Self-citation
Cited by
Endothelial Dysfunction: A Marker of Atherosclerotic Risk
Bonetti, P. O., Lerman, L. O., & Lerman, A. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000051384.43104.fc · Cited by 2,200
Hwang, S.-J., Ballantyne, C. M., Sharrett, A. R., Smith, L. C., Davis, C. E., Gotto, A. M., & Boerwinkle, E. (1997) · Circulation · doi:10.1161/01.cir.96.12.4219 · Cited by 1,344
Endothelial Function: Cardiac Events
Lerman, A., & Zeiher, A. M. (2005) · Circulation · doi:10.1161/01.cir.0000153339.27064.14 · Cited by 1,096
Self-citationINFLAMMATION AND ATHEROSCLEROSIS
Hansson, G. K., Robertson, A.-K. L., & Söderberg-Nauclér, C. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100100 · Cited by 1,046
Lüscher, T. F., & Barton, M. (2000) · Circulation · doi:10.1161/01.cir.102.19.2434 · Cited by 596
Metadata
- Authors
- Zeiher, A. M., Goebel, H., Schächinger, V., & Ihling, C.
- Venue
- Circulation
- Published
- 1995-02-15
- Volume
- 91
- Issue
- 4
- Pages
- 941-947
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2087350450
- Cited by
- 280
- References
- 40
- FWCI
- 13.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.